NCT03984448 2026-04-13
Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas
National Cancer Institute (NCI)
Phase 2/3 Active not recruiting
National Cancer Institute (NCI)
Children's Cancer Group, China
Children's Oncology Group
St. Jude Children's Research Hospital
Universitätsklinikum Hamburg-Eppendorf